Vaccine Development for Cytomegalovirus

• Abel K, Martinez J, Yue Y et al (2011) Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques. J Virol 85:2878–2890

  Article  PubMed  CAS  Google Scholar 

• Adler SP (2008) Human CMV vaccine trials: what if CMV caused a rash? J Clin Virol 41:231–236

  Article  PubMed  CAS  Google Scholar 

• Adler SP, Starr SE, Plotkin SA et al (1995) Immunity induced by primary human cytomegalovirus-infection protects against secondary infection among women of childbearing age. J Infect Dis 171:26–32

  Article  PubMed  CAS  Google Scholar 

• Adler SP, Plotkin SA, Gonczol E et al (1999) A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). J Infect Dis 180:843–846

  Article  PubMed  CAS  Google Scholar 

• Adler SP, Manganello AM, Lee R et al (2016) A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimera vaccines in cytomegalovirus-seronegative men. J Infect Dis 214:1341–1348

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Adler S, Lewis N, Conlon A et al (2017) Phase 1 clinical trial of a replication-defective human cytomegalovirus (CMV) vaccine. ID Week 2017 presentation

  Google Scholar 

• Arav-Boger R, Wojcik GL, Duggal P et al (2012) Polymorphisms in toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine. BMC Res Notes 5:140

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Arvin AM, Fast P, Myers M et al (2004) Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis 39:233–239

  Article  PubMed  Google Scholar 

• Assaf BT, Mansfield KG, Strelow L et al (2014) Limited dissemination and shedding of the UL128 complex-intact, UL/b’-defective rhesus cytomegalovirus strain 180.92. J Virol 88:9310–9320

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Auerbach MR, Yan D, Vij R et al (2014) A neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection. PLoS Pathog 10:e1004060

  Article  PubMed  PubMed Central  Google Scholar 

• Barry PA, Lockridge KM, Salamat S et al (2006) Nonhuman primate models of intrauterine cytomegalovirus infection. ILAR J 47:49–64

  Article  PubMed  CAS  Google Scholar 

• Berencsi K, Gyulai Z, Gönczöl E et al (2001) A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects. J Infect Dis 183:1171–1179

  Article  PubMed  CAS  Google Scholar 

• Bernstein DI, Reap EA, Katen K et al (2009) Randomized, double-blind, phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. Vaccine 28:484–493

  Article  PubMed  CAS  Google Scholar 

• Bernstein DI, Munoz FM, Callahan ST et al (2016) Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial. Vaccine 34:313–319

  Article  PubMed  CAS  Google Scholar 

• Bialas KM, Tanaka T, Tran D et al (2015) Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission. Proc Natl Acad Sci U S A 112:13645–13650

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Boppana SB, Britt WJ (1995) Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 171:1115–1121

  Article  PubMed  CAS  Google Scholar 

• Britt WJ (2017) Congenital human cytomegalovirus infection and the enigma of maternal immunity. J Virol 91:e02392-16

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Bunde T, Kirchner A, Hoffmeister B et al (2005) Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 201:1031–1036

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Burwitz BJ, Malouli D, Bimber BN et al (2016) Cross-species rhesus cytomegalovirus infection of cynomolgus macaques. PLoS Pathog 12:e1006014

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Cardin RD, Bravo FJ, Pullum DA et al (2016) Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection. Vaccine 34:1993–1999

  Article  PubMed  CAS  Google Scholar 

• Cayatte C, Schneider-Ohrum K, Wang Z et al (2013) Cytomegalovirus vaccine strain Towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells. J Virol 87:11107–11120

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Cha TA, Tom E, Kemble GW et al (1996) Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70:78–83

  PubMed  PubMed Central  CAS  Google Scholar 

• Chandramouli S, Malito E, Nguyen T et al (2017) Structural basis for potent antibody-mediated neutralization of human cytomegalovirus. Sci Immunol 2:eaan1457

  Article  PubMed  Google Scholar 

• Chang WLW, Barry PA (2010) Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity. Proc Natl Acad Sci U S A 107:22647–22652

  Article  PubMed  PubMed Central  Google Scholar 

• Chang WL, Baumgarth N, Yu D, Barry PA (2004) Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J Virol 78:8720–8731

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Chatterjee A, Harrison CJ, Britt WJ, Bewtra C (2001) Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs. J Infect Dis 183:1547–1553

  Article  PubMed  CAS  Google Scholar 

• Chaudhuri S, Lowen B, Chan G et al (2009) Human cytomegalovirus interacts with toll-like receptor 2 and CD14 on syncytiotrophoblasts to stimulate expression of TNFα mRNA and apoptosis. Placenta 30:994–1001

  Article  PubMed  CAS  Google Scholar 

• Chiuppesi F, Wussow F, Johnson E et al (2015) Vaccine-derived neutralizing antibodies to the human cytomegalovirus gH/gL pentamer potently block primary cytotrophoblast infection. J Virol 89:11884–11898

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Chiuppesi F, Kaltcheva T, Meng Z et al (2017) Identification of a continuous neutralizing epitope within UL128 of human cytomegalovirus. J Virol 91:e01857–e01816

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Ciferri C, Chandramouli S, Donnarumma D et al (2015a) Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes. Proc Natl Acad Sci U S A 112:1767–1772

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Ciferri C, Chandramouli S, Leitner A et al (2015b) Antigenic characterization of the HCMV gH/gL/gO and Pentamer cell entry complexes reveals binding sites for potently neutralizing human antibodies. PLoS Pathog 11:e1005230

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Coaquette A, Bourgeois A, Dirand C et al (2004) Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 39:155–161

  Article  PubMed  Google Scholar 

• Corrales-Aguilar E, Trilling M, Hunold K et al (2014) Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III. PLoS Pathog 10:e1004131

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Crumpler MM, Choi KY, McVoy MA, Schleiss MR (2009) A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection. Vaccine 27:4209–4218

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Cui X, Meza BP, Adler SP, McVoy MA (2008) Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection. Vaccine 26:5760–5766

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Dempsey AF, Pangborn HM, Prosser LA (2012) Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus. Vaccine 30:4060–4066

  Article  PubMed  Google Scholar 

• Dropulic LK, Cohen JI (2012) The challenge of developing a herpes simplex virus 2 vaccine. Expert Rev Vaccines 11:1429–1440

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Eberhardt MK, Deshpande A, Chang WLW et al (2013) Vaccination against a virus-encoded cytokine significantly restricts viral challenge. J Virol 87:11323–11331

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Elkington R, Walker S, Crough T et al (2003) Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 77:5226–5240

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Fan Q, Nelson CS, Bialas KM et al (2017) Plasmablast response to primary rhesus cytomegalovirus infection in a monkey model of congenital CMV transmission. Clin Vaccine Immunol 24:e00510-16

  Google Scholar 

• Fornara C, Cassaniti I, Zavattoni M et al (2017) Human cytomegalovirus-specific memory CD4+ T-Cell response and its correlation with virus transmission to the fetus in pregnant women with primary infection. Clin Infect Dis 65:1659–1665

  Article  PubMed  Google Scholar 

• Fouts AE, Chan P, Stephan J-PP et al (2012) Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin. J Virol 86:7444–7447

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Fowler KB, Stagno S, Pass RF et al (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326:663–667

  Article  PubMed  CAS  Google Scholar 

• Fowler KB, Stagno S, Pass RF (2003) Maternal immunity and prevention of congenital cytomegalovirus infection. J Am Med Assoc 289:1008–1011

  Article  Google Scholar 

• Freed DC, Tang Q, Tang A et al (2013) Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine. Proc Natl Acad Sci U S A 110:E4997–E5005

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Fu TM, Wang D, Freed DC et al (2012) Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus. Vaccine 30:7469–7474

  Article  PubMed  CAS  Google Scholar 

• Fukui Y, Shindoh K, Yamamoto Y et al (2008) Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay. Antimicrob Agents Chemother 52:2420–2427

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Gerna G, Sarasini A, Patrone M et al (2008) Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J Gen Virol 89:853–865

  Article  PubMed  CAS  Google Scholar 

• Gillis PA, Hernandez-Alvarado N, Gnanandarajah JS et al (2014) Development of a novel, guinea pig-specific IFN-gamma ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine. Vaccine 32:3963–3970

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Griffiths PD, Stanton A, McCarrell E et al (2011) Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet 377:1256–1263

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Ha S, Li F, Troutman MC et al (2017) Neutralization of diverse human cytomegalovirus strains conferred by antibodies targets viral gH/gL/pUL128-131 pentameric complex. J Virol 91:e02033–e02016

  PubMed  PubMed Central  Google Scholar 

• Hahn G, Revello MG, Patrone M et al (2004) Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78:10023–10033

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Hansen SG, Strelow LI, Franchi DC et al (2003) Complete sequence and genomic analysis of rhesus cytomegalovirus. J Virol 77:6620–6636

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Hashimoto K, Yamada S, Katano H et al (2013) Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta. Vaccine 31:3199–3205

  Article  PubMed  CAS  Google Scholar 

• Heineman TC, Schleiss M, Bernstein DI et al (2006) A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines. J Infect Dis 193:1350–1360

  Article  PubMed  CAS  Google Scholar 

• Ikuta K, Minematsu T, Inoue N et al (2013) Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers. J Clin Virol 58:474–478

  Article  PubMed  CAS  Google Scholar 

• Ishibashi K, Tokumoto T, Tanabe K et al (2007) Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes. Clin Infect Dis 45:60–67

  Article  PubMed  CAS  Google Scholar 

• Jacobson MA, Adler SP, Sinclair E et al (2009) A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain). Vaccine 27:1540–1548

  Article  PubMed  CAS  Google Scholar 

• Kabanova A, Perez L, Lilleri D et al (2014) Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies. Proc Natl Acad Sci U S A 111:17965–17970

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Kang SH, Abdel-Massih RC, Brown RA et al (2012) Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation. J Infect Dis 205:639–646

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Katano H, Sato Y, Tsutsui Y et al (2007) Pathogenesis of cytomegalovirus-associated labyrinthitis in a guinea pig model. Microbes Infect 9:183–191

  Article  PubMed  CAS  Google Scholar 

• Kaufmann P, Davidoff M (1977) The guinea-pig placenta. Adv Anat Embryol Cell Biol 53:5–91

  PubMed  CAS  Google Scholar 

• Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253–276

  Article  PubMed  Google Scholar 

• Kharfan-Dabaja MA, Boeckh M, Wilck MB et al (2012) A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 12:290–299

  Article  PubMed  CAS  Google Scholar 

• Kirchmeier M, Fluckiger AC, Soare C et al (2014) Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity. Clin Vaccine Immunol 21:174–180

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Koyano S, Inoue N, Nagamori T et al (2009) Dried umbilical cords in the retrospective diagnosis of congenital cytomegalovirus infection as a cause of developmental delays. Clin Infect Dis 48:e93–e95

  Article  PubMed  Google Scholar 

• Koyano S, Inoue N, Oka A et al (2011) Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open 1:e000118

  Article  PubMed  PubMed Central  Google Scholar 

• Krause PR, Bialek SR, Boppana SB et al (2013) Priorities for CMV vaccine development. Vaccine 32:4–10

  Article  PubMed  PubMed Central  Google Scholar 

• La Rosa C, Longmate J, Lacey SF et al (2012) Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant. J Infect Dis 205:1294–1302

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• La Rosa C, Longmate J, Martinez J et al (2017) MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults. Blood 129:114–125

  Article  PubMed  PubMed Central  Google Scholar 

• La Torre R, Nigro G, Mazzocco M et al (2006) Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 43:994–1000

  Article  PubMed  Google Scholar 

• Lacey SF, La Rosa C, Zhou W et al (2006) Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients. J Infect Dis 194:1410–1421

  Article  PubMed  CAS  Google Scholar 

• Landais I, Pelton C, Streblow D et al (2015) Human cytomegalovirus miR-UL112-3p targets TLR2 and modulates the TLR2/IRAK1/NFκB signaling pathway. PLoS Pathog 11:e1004881

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Leviton MP, Lacayo JC, Choi KY et al (2013) An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model. Clin Dev Immunol 2013:906948

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Lilja AE, Shenk T (2008) Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types. Proc Natl Acad Sci U S A 105:19950–19955

  Article  PubMed  PubMed Central  Google Scholar 

• Lilleri D, Fornara C, Furione M et al (2007) Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. J Infect Dis 195:1062–1070

  Article  PubMed  Google Scholar 

• Lilleri D, Kabanova A, Lanzavecchia A, Gerna G (2012) Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo. J Clin Immunol 32:1324–1331

  Article  PubMed  CAS  Google Scholar 

• Lilleri D, Kabanova A, Revello MG et al (2013) Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection. PLoS One 8:e0059863

  Article  CAS  Google Scholar 

• Loomis RJ, Lilja AE, Monroe J et al (2013) Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies. Vaccine 31:919–926

  Article  PubMed  CAS  Google Scholar 

• Loughney JW, Rustandi RR, Wang D et al (2015) Soluble human cytomegalovirus gH/gL/pUL128-131 pentameric complex, but not gH/gL, inhibits viral entry to epithelial cells and presents dominant native neutralizing epitopes. J Biol Chem 290:15985–15995

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Macagno A, Bernasconi NL, Vanzetta F et al (2010) Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex. J Virol 84:1005–1013

  Article  PubMed  CAS  Google Scholar 

• Maidji E, McDonagh S, Genbacev O et al (2006) Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 168:1210–1226

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Majima R, Shindoh K, Yamaguchi T, Inoue N (2017) Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62. Antivir Res 140:142–150

  Article  PubMed  CAS  Google Scholar 

• Malouli D, Nakayasu ES, Viswanathan K et al (2012) Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1. J Virol 86:8959–8973

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Marsh AK, Willer DO, Ambagala APN et al (2011) Genomic sequencing and characterization of cynomolgus macaque cytomegalovirus. J Virol 85:12995–13009

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Mele F, Fornara C, Jarrossay D et al (2017) Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission. PLoS One 12:e0187731

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• McDonagh S, Maidji E, Chang HT, Pereira L (2006) Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis. J Clin Virol 35:210–215

  Article  PubMed  CAS  Google Scholar 

• Mori T, Kanda Y, Takenaka K et al (2017) Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial. Int J Hematol 105:206–212

  Article  PubMed  CAS  Google Scholar 

• Nahum A, Dadi H, Bates A, Roifman CM (2012) The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity. Autoimmun Rev 11:341–347

  Article  PubMed  CAS  Google Scholar 

• Nakamura R, Rosa C, La LJ et al (2016) Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial. Lancet Haematol 3:e87–e98

  Article  Google Scholar 

• NCT01974206 News release (2016) HP of Vical (www.vical.com/investors/news-releases/News-Release-Details/2016/Vical-and-Astellas-Announce-Topline-Results-from-a-Phase-2-Study-of-Investigational-Cytomegalovirus-CMV-Vaccine-ASP0113-in-Kidney-Transplant-Patients/default.aspx)

• NCT01877655 News release (2017) HP of Vical (www.vical.com/investors/news-releases/News-Release-Details/2017/Vical-Announces-Completion-of-the-Phase-3-ASP0113-CMV-Vaccine-Trial/default.aspx)

• NCT02798692 News release (2017) HP of Hooki (www.29c5yd3ksizu1pn67922fy74.wpengine.netdna-cdn.com/wp-content/uploads/2017/05/Hookipa-press-release-HB-101-Data-at-CMV-Conference-4-May-2017.pdf)

• NCT02826798 News release (2017) HP of VBI vacinnes (www.vbivaccines.com/wire/cmv-phase-i-clinical-study-update-may-2017/)

• Nelson CS, Cruz DV, Tran D et al (2017) Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys. JCI Insight 2:94002

  Google Scholar 

• Nozawa N, Koyano S, Yamamoto Y et al (2007) Real-time PCR assay using specimens on filter disks as a template for detection of cytomegalovirus in urine. J Clin Microbiol 45:1305–1307

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Nozawa N, Yamamoto Y, Fukui Y et al (2008) Identification of a 1.6 kb genome locus of guinea pig cytomegalovirus required for efficient viral growth in animals but not in cell culture. Virology 379:45–54

  Article  PubMed  CAS  Google Scholar 

• Nozawa N, Fang-Hoover J, Tabata T et al (2009) Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream. J Clin Virol 46:S58–S63

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Ogawa H, Suzutani T, Baba Y et al (2007) Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and mutations. J Infect Dis 195:782–788

  Article  PubMed  CAS  Google Scholar 

• Pass RF, Duliegè AM, Boppana S et al (1999) A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J Infect Dis 180:970–975

  Article  PubMed  CAS  Google Scholar 

• Pass RF, Zhang C, Evans A et al (2009) Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 360:1191–1199

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Peggs KS, Verfuerth S, Pizzey A et al (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet 362:1375–1377

  Article  PubMed  Google Scholar 

• Pepperl S, Münster J, Mach M et al (2000) Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression. J Virol 74:6132–6146

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Pereira L, Maidji E, McDonagh S et al (2003) Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J Virol 77:13301–13314

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Petty TJ, Todd Callahan S, Chen Q et al (2010) Assessment of parental acceptance of a potential cytomegalovirus vaccine for adolescent females. Vaccine 28:5686–5690

  Article  PubMed  PubMed Central  Google Scholar 

• Puchhammer-Stockl E, Gorzer I (2006) Cytomegalovirus and Epstein-Barr virus subtypes--the search for clinical significance. J ClinVirol 36:239–248

  Google Scholar 

• Raftery MJ, Wieland D, Gronewald S et al (2004) Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J Immunol 173:3383–3391

  Article  PubMed  CAS  Google Scholar 

• Reap EA, Morris J, Dryga SA et al (2007) Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus. Vaccine 25:7441–7449

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Revello MG, Lilleri D, Zavattoni M et al (2006) Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers. J Infect Dis 193:269–276

  Article  PubMed  Google Scholar 

• Revello MG, Lazzarotto T, Guerra B et al (2014) A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 370:1316–1326

  Article  PubMed  CAS  Google Scholar 

• Riddell SR, Watanabe KS, Goodrich JM et al (1992) Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238–241

  Article  PubMed  CAS  Google Scholar 

• Ross SA, Arora N, Novak Z et al (2010) Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 201:386–389

  Article  PubMed  Google Scholar 

• Russell JNH, Marsh AK, Willer DO et al (2016) A novel strain of cynomolgus macaque cytomegalovirus: implications for host-virus co-evolution. BMC Genomics 17:1–17

  Article  CAS  Google Scholar 

• Schleiss MR, Bourne N, Bernstein DI (2003) Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection. J Infect Dis 188:1868–1874

  Article  PubMed  CAS  Google Scholar 

• Schleiss MR, Bourne N, Stroup G et al (2004) Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine. J Infect Dis 189:1374–1381

  Article  PubMed  CAS  Google Scholar 

• Schleiss MR, Stroup G, Pogorzelski K, McGregor A (2006) Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine. Vaccine 24:6175–6186

  Article  PubMed  CAS  Google Scholar 

• Schleiss MR, Lacayo JC, Belkaid Y et al (2007) Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection. J Infect Dis 195:789–798

  Article  PubMed  CAS  Google Scholar 

• Schleiss MR, Choi KY, Anderson J et al (2014) Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model. Vaccine 32:2756–2762

  Article  PubMed  CAS  Google Scholar 

• Schleiss MR, Bierle CJ, Swanson EC et al (2015) Vaccination with a live attenuated cytomegalovirus devoid of a protein kinase R inhibitory gene results in reduced maternal viremia and improved pregnancy outcome in a guinea pig congenital infection model. J Virol 89:9727–9738

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Schleiss MR, Berka U, Watson E et al (2017) Additive protection against congenital cytomegalovirus conferred by combined glycoprotein B/pp65 vaccination using a lymphocytic choriomeningitis virus vector. ClinVaccine Immunol 24:e00300–e00316

  CAS  Google Scholar 

• Schneider-Ohrum K, Cayatte C, Liu Y et al (2016) Production of cytomegalovirus dense bodies by scalable bioprocess methods maintains immunogenicity and improves neutralizing antibody titers. J Virol 90:10133–10144

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Scott GM, Chow SS, Craig ME et al (2012) Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J Infect Dis 205:1305–1310

  Article  PubMed  CAS  Google Scholar 

• Siewiera J, El Costa H, Tabiasco J et al (2013) Human cytomegalovirus infection elicits new decidual natural killer cell effector functions. PLoS Pathog 9:e1003257

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Slavuljica I, Busche A, Babić M et al (2010) Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest 120:4532–4545

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Stratton KR, Durch JS, Lawrence RS (2000) Vaccines for the 21st century. National Academy Press, Washington, DC

  Google Scholar 

• Swanson EC, Gillis P, Hernandez-Alvarado N et al (2015) Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against p. Vaccine 33:4013–4018

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Sylwester A, Mitchell B, Edgar J et al (2005) Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202:673–685

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Taniguchi R, Koyano S, Suzutani T et al (2013) Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) infection but not with congenital CMV disease. Int J Infect Dis 17:e1092–e1097

  Article  PubMed  CAS  Google Scholar 

• Tomić A, Varanasi PR, Golemac M et al (2016) Activation of innate and adaptive immunity by a recombinant human cytomegalovirus strain expressing an NKG2D ligand. PLoS Pathog 12:e1006015

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Walter EA, Greenberg PD, Gilbert MJ et al (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333:1038–1044

  Article  PubMed  CAS  Google Scholar 

• Wang D, Shenk T (2005a) Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci U S A 102:18153–18158

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Wang D, Shenk T (2005b) Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J Virol 79:10330–10338

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Wang Z, La Rosa C, Maas R et al (2004) Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus. J Virol 78:3965–3976

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Wang D, Li F, Freed DC et al (2011) Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection. Vaccine 29:9075–9080

  Article  PubMed  CAS  Google Scholar 

• Wang D, Freed DC, He X et al (2016) A replication-defective human cytomegalovirus vaccine for prevention of congenital infection. Sci Transl Med 8:362ra145

  Article  PubMed  CAS  Google Scholar 

• Weisblum Y, Panet A, Zakay-Rones Z et al (2011) Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture. J Virol 85:13204–13213

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Weisblum Y, Panet A, Zakay-Rones Z et al (2015) Human cytomegalovirus induces a distinct innate immune response in the maternal-fetal interface. Virology 485:289–296

  Article  PubMed  CAS  Google Scholar 

• Wen Y, Monroe J, Linton C et al (2014) Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice. Vaccine 32:3796–3804

  Article  PubMed  CAS  Google Scholar 

• Wussow F, Yue Y, Martinez J et al (2013) A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques. J Virol 87:1322–1332

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Wussow F, Chiuppesi F, Martinez J et al (2014) Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex. PLoS Pathog 10:e1004524

  Article  PubMed  PubMed Central  CAS  Google Scholar 

• Yamada S, Nozawa N, Katano H et al (2009) Characterization of the guinea pig cytomegalovirus genome locus that encodes homologs of human cytomegalovirus major immediate-early genes, UL128, and UL130. Virology 391:99–106

  Article  PubMed  CAS  Google Scholar 

• Yamada S, Fukuchi S, Hashimoto K et al (2014) Guinea pig cytomegalovirus GP129/131/133, homologues of human cytomegalovirus UL128/130/131A, are necessary for infection of monocytes and macrophages. J Gen Virol 95:1376–1382

  Article  PubMed  CAS  Google Scholar 

• Yue Y, Kaur A, Zhou SS, Barry PA (2006) Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65). J Gen Virol 87:777–787

  Article  PubMed  CAS  Google Scholar 

• Yue Y, Kaur A, Eberhardt MK et al (2007) Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques. J Virol 81:1095–1109

  Article  PubMed  CAS  Google Scholar 

• Yue Y, Wang Z, Abel K et al (2008) Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques. Med Microbiol Immunol 197:117–123

  Article  PubMed  CAS  Google Scholar 

Download references